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Paralysis of Dendritic Cell IL-12 Production
by Microbial Products Prevents
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laboratory mice, which results in IFNg-dependent con-
trol of both acute and chronic infection (Sher et al., 1995;
Gazzinelli et al., 1998). In the absence of IL-10, however,
normally avirulent T. gondii infections become patho-
genic, resulting in acute mortality associated with ex-
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p40 and p70 measured either in vitro or in situ (Reis e
Sousa et al., 1997). This response occurs concurrently
with the migration of splenic DC from the marginal zoneSummary
into the T lymphocyte areas (periarteriolar sheaths
[PALS]) and thus may reflect the initiation of T cell acti-Interleukin-12 plays a major role in immunity to intra-
cellular pathogens by governing the development of vation.
While IL-12 synthesis by DC in response to STAg isIFNg-dependent host resistance. Nevertheless, unreg-
ulated IL-12 synthesis can lead to immunopathology, rapid and intense, it is relatively short-lived, returning
to baseline levels by 24 hr post-injection (Reis e Sousaan outcome prevented by the concurrent expression
of interleukin-10. Dendritic cells (DC) are an important et al., 1997). Because this transience would appear to
be biologically useful in protecting the host against thesource of the initial IL-12 stimulated by microbial
agents. Here, we show that, following systemic trig- detrimental effects of sustained IL-12 production, we
decided in the present study to investigate its cellulargering, DC can no longer be restimulated to produce
IL-12 in vivo while continuing to respond in vitro. When basis. Unexpectedly, we found that once IL-12 synthesis
ceases in vivo, it cannot be restimulated at normal levelsinfected with Toxoplasma gondii during this refractory
state, mice mount impaired acute IFNg responses and, for a period of almost 1 week. Nonetheless, DC isolated
from such ªparalyzedº mice produce IL-12 in responsein the case of IL-10-deficient animals, are protected
from cytokine-induced mortality. These findings dem- to STAg in culture, implying that the failure to produce
the cytokine upon stimulation in vivo is not due to intrin-onstrate a previously unrecognized form of immuno-
logic paralysis involving DC that can protect from in- sic DC unresponsiveness or cell death but to an effect
of the splenic microenvironment. This STAg-induced pa-fection-induced immunopathology.
ralysis of IL-12 production is reflected in systemic reduc-
tions in both IL-12 and IFNg in serum upon restimulation.Introduction
Strikingly, the process protects IL-10-deficient mice
against the IFNg-dependent lethality induced by live T.An important consequence of dendritic cell (DC) en-
gondii infection. The paralysis of IL-12 synthesis de-counter with microbial products is the production of
scribed may reflect a normal physiologic process thatinterleukin-12 (IL-12) (Reis e Sousa et al., 1999). This
allows the initiation of innate and cell-mediated immunityproinflammatory cytokine stimulates IFNg-dependent
to invading microbes while limiting the immunopatho-innate resistance as well as promoting the development
logic effects of prolonged exposure to the cytokine.of Th1 cells important in adaptive immunity (Hsieh et
al., 1993; Trinchieri, 1998). Since excess IL-12 and IFNg
can lead to lethal tissue damage, the production of the Results
mediator must be tightly regulated. Interleukin-10, a cy-
tokine usually synthesized together with IL-12, plays a The Microbe-Induced IL-12 p40 Response of Splenic
CD8a1 DC In Vivo Is Short Livedmajor host protective function by downregulating IL-
12 expression (Howard et al., 1993; Berg et al., 1995; We have previously reported that injection of mice with
a soluble extract of tachyzoites of the parasite T. gondiiTrinchieri, 1998).
We have been studying a model system for the initia- elicits production of high levels of IL-12 by a CD8a1
subpopulation of splenic DC (Reis e Sousa et al., 1997).tion of immune responses by DC that involves the intra-
cellular pathogen, Toxoplasma gondii. This protozoan IL-12 production in response to this stimulus is transient,
peaking at around 6±12 hr after injection and returninginduces a strong IL-12 response early after invasion of
to baseline levels by 24 hr post stimulation, as measured
by accumulation of IL-12 p40 in culture supernatants of³ To whom correspondence should be addressed (e-mail: caetano@
spleen cells from STAg-injected mice (Figure 1A). Immuno-icrf.icnet.uk [C. R. S.], alan_sher@nih.gov [A. S.]).
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Immunity
638
Figure 1. Kinetics and Characteristics of the IL-12 Response after In Vivo STAg Challenge
(A) IL-12 production by spleen cells isolated from C57BL/10 or B10-IL-10 KO mice (3±4/group) at the indicated times following i.v. injection
of STAg (25 mg). All animals were sacrificed at the same time, and cells were isolated by mechanical dissociation of spleens and were cultured
for 24 hr in medium. IL-12 p40 released into supernatants was measured by ELISA. Data shown are mean 6 SD of values determined on
individual mice in each group and are representative of two experiments performed.
(B) IL-12 production by DC in situ is transient and is not due to bulk loss of splenic CD11c1 cells. C57BL/6 mice (3±4/group) were injected
i.v. with STAg (25 mg), and at various time points the animals were sacrificed. Some of the animals within the original group were reinjected
i.v. with STAg (25 mg) at 24 hr and day 7 post injection and sacrificed 6 hr later. Adjacent frozen spleen sections were stained with either
CD11c to identify total DC (left of duplicate panels) or anti-IL-12 p40 (right panels). The micrographs shown are representative of multiple
sections analyzed from at least two mice per group. Original magnification, 3100.
(C) IL-12 p40 expression is restricted to the CD8a1 DC subset. Splenocytes from CBA/J mice injected with PBS or STAg 6 hr previously were
fixed, permeabilized, and stained with anti-CD11c, anti-CD8a, and anti-IL-12 p40. Cells were analyzed for expression of CD8a and IL-12 p40
after gating on CD11cbright cells. Data are representative of at least 10 experiments. Numbers indicate the percentage of cells in each quadrant.
(D) STAg does not induce DC apoptosis in vivo. Detection of apoptotic cells by TUNEL on spleen sections 14 hr after i.v. injection of PBS,
25 mg STAg, or 25 mg LPS. Apoptotic cells are stained brown. The methyl green counterstain outlines the white pulp. Original magnification,
3100.
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Table 2. DC Frequencies in Mouse Spleen after STAg ChallengeTable 1. Frequencies of Apoptotic DC in Mouse Spleen after
Challenge
CD8 Negative DC CD8 Positive DC
CD8 Negative DC CD8 Positive DC
Treatment Mean SD Mean SD
Treatment Mean SD Mean SD
PBS→PBS 100.0 0.0 100.00 0.00
PBS→STAg 104.2 28.3 84.96 17.09PBS 12.8 0.28 15.9 0.32
STAg 7.83 0.98 11.8 0.51 STAg→PBS 93.5 11.6 83.88 13.41
STAg→STAg 92.4 19.0 62.23 24.02LPS 22.9 0.55 19.3 0.88
The mean frequency of CD11c1 CD8a2 and CD11c1 CD8a1 cellsThe percentage of CD11c1 CD8a2 and CD11c1 CD8a1 cells that
stained positive with annexin V was determined by flow cytometric was determined by flow cytometric analysis of spleen cells from
mice receiving the indicated treatments. Dead cells were eliminatedanalysis of spleen cells prepared 14 hr after i.v. injection of mice
with the indicated stimuli. Data are the average of values obtained from the analysis based on scatter profiles and/or TOPRO staining.
Data are expressed as the frequency of each subset relative to thatfrom three mice per group. SD, standard deviation.
in the PBS→PBS control group and represent the average of n 5
4 independent experiments. SD, standard deviation. The mean fre-
quencies of CD8a2 and CD8a1 DC in the PBS→PBS control group
were 1.03% 6 0.47 and 0.67% 6 0.13, respectively.the IL-12 p40 staining at 6 hr after STAg challenge colo-
calized with staining for CD11c, a DC marker (Figure
1B, left side). Flow cytometric analysis confirmed that
only CD11cbright cells, corresponding to splenic DC, with either PBS or STAg 24 hr after the first stimulus.
stained with an antibody against IL-12 p40 at 6 hr post Four hours later, animals were sacrificed, and spleno-
injection (data not shown) and that these DC were cyte suspensions were analyzed for the presence of DC
CD8a1 (Figure 1C). The IL-12 staining was specific be- subsets. Splenic CD8a1 DC were present at an average
cause it was not seen using an irrelevant isotype- of 80% of their original frequency after STAg→PBS in-
matched control antibody (data not shown) and was jection, while little change was seen in the frequency of
dependent on STAg challenge (Figure 1C). On average, CD8a2 DC (Table 2). Total spleen cell numbers varied
40%±60% of all splenic CD8a1 DC stained for IL-12 p40 by less than 10% between groups, resulting in approxi-
at 4±6 hr after STAg challenge (Figure 1C), although ex mately the same differences in total DC numbers as in
vivo incubation with brefeldin A prior to fixation in- DC frequency. Together, these results suggest that most
creased this value to 70%±90% (data not shown). Con- DC remain viable in the spleen at 24 hr post STAg chal-
sistent with the loss of IL-12 detection in supernatants lenge and, therefore, loss of IL-12 detection cannot be
of unfractionated spleen cells (Figure 1A), IL-12 p40 attributed to DC death.
staining of DC was no longer detectable 24 hr post IL-10 is an important cytokine involved in downmodu-
injection with STAg, either in situ (Figure 1B, left panel) lating IL-12 synthesis (Trinchieri, 1998). To assess the
or by FACS (data not shown). possible role of IL-10 in shutting down IL-12 production
by DC in vivo, the kinetics of the STAg response were
compared between IL-10-sufficient and IL-10-deficientThe Decline in the Splenic IL-12 Response Is Not
Attributable to Death of DC or IL-10 Suppression mice. As shown in Figure 1A, spleen cells from IL-10
KO mice produced slightly higher levels of IL-12 thanDC activation by LPS in vivo results in cell loss by apo-
ptotic death and is reflected in reduced numbers of cells from control mice at 6 hr after STAg challenge.
However, termination of the IL-12 response at 24 hr postCD11c1 cells detectable by immunohistochemical stain-
ing of spleen sections 24±48 hr after LPS challenge (De injection still occurred in IL-10 KO mice as in wild-type
controls, suggesting that IL-10 is not responsible for theSmedt et al., 1996). Importantly, there was no reduction
in the number of cells staining for CD11c in spleen sec- loss of IL-12 synthesis.
tions 24 hr after STAg injection (Figure 1B, left side).
Similarly, analysis of spleen sections by TUNEL staining Ability of DC to Produce IL-12 In Vivo Is Abrogated
by Prior Stimulationrevealed a few apoptotic cells in the red pulp of PBS-
injected mice but no increase in numbers or change in We examined whether a second STAg injection could
reelicit IL-12 production in mice previously exposed todistribution of dying cells after STAg challenge (Figure
1D). In contrast, numerous apoptotic cells in the white the microbial stimulus. Mice were given two injections
24 hr apart and sacrificed 4 hr after the second injection.pulp were readily detected after LPS injection (Figure
1D; data not shown), as reported (De Smedt et al., 1998). Splenocyte suspensions were prepared and cultured in
medium for 24 hr, and release of IL-12 into supernatantsTo quantitate DC apoptosis directly, spleen cell suspen-
sions were stained with annexin V and labeled for DC was measured (Figure 2A, dotted bars). No IL-12 was
detected in supernatants of spleen cells from mice thatsubset markers. Surprisingly, as many as 16% of CD8a1
CD11c1 and 13% of CD8a2 CD11c1 cells could be were injected first with STAg followed by PBS (Figure
2A, STAg→PBS, dotted bars; compare with PBS→PBSstained with annexin V after PBS injection (Table 1).
STAg injection decreased by 25%±35% the fraction of control mice), consistent with the fact that the response
to the primary stimulus had already waned by 28 hr postCD8a1 DC undergoing apoptosis, in contrast to LPS,
which increased it by as much as 100% (Table 1). challenge (Figure 1). In animals given PBS followed by
STAg, large amounts of IL-12 accumulated in spleenFACS analysis of DC frequencies was also performed
to examine whether loss of splenic DC occurred by non- cell supernatants in the absence of further stimulation,
as before (Figure 2A, PBS→STAg, dotted bars). Remark-apoptotic death or emigration. Animals were given a
primary injection with STAg or PBS and were reinjected ably, in mice given two injections of STAg there was no
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Figure 2. STAg Administration Leads to DC
Paralysis that Is Reversible In Vitro
(A) C57BL/6 mice were injected i.p. with either
PBS, STAg (25 mg), or LPS (25 mg), followed
by a second PBS, LPS, or STAg injection 24
hr later, as indicated. All mice received two
injections to account for any stress-induced
changes in DC and were sacrificed 28 hr after
the first injection. Splenocyte suspensions
were prepared and cultured at 2 3 105/well
for 24 hr in complete medium in the presence
or absence of 5 mg/ml STAg. Supernatants
were assayed for IL-12 p40 by ELISA. Data
are expressed as ng/ml. Experiment shown
is representative of over six performed.
(B) CD11c2, CD11c1 CD8a2, and CD11c1
CD8a1 subsets were sorted from spleens
taken from mice injected i.p. 24 hr previously
with PBS or STAg (25 mg). The total spleen
cell populations and sorted subsets were cul-
tured as in (A). Data presented are expressed
as fg/ml of IL-12 p40 in the supernatant di-
vided by the total number of cells added to
the well in order to account for different num-
bers of sorted cells from each subset. Experi-
ment is one of two performed. Data in (A) and
(B) are the means of triplicate cultures. All
error bars are shown and represent one SD.
production of IL-12 in response to the second challenge loss of the ability of these cells to make the cytokine or
(Figure 2A, STAg→STAg, dotted bars). Identical results due to an in vivo immunosuppressive effect. To address
were obtained when IL-12 production by DC was as- this issue, spleen cells from the experiment in Figure 2
sessed by intracellular staining rather than by cytokine were also cultured in vitro in the presence of STAg. In
secretion (data not shown). These findings suggest that vitro stimulation of spleen cells from PBS→PBS mice
systemic STAg stimulation results in the inability of DC with STAg induced IL-12 accumulation in supernatants
to make IL-12 in response to further challenge in vivo. (Figure 2A, shaded bars, PBS→PBS), consistent with
We have termed this phenomenon ªDC paralysis.º the effects of this microbial product in vivo. Culture
To determine whether the induction of DC paralysis of spleen cells from PBS→STAg mice with STAg re-
in the spleen results in systemic suppression of IL-12 sulted in a slight increase in the level of IL-12 in superna-
production, levels of the cytokine were measured in the tants over that found with medium alone (Figure 2A,
sera of mice preinjected with PBS or STAg prior to final shaded bars, PBS→STAg). Remarkably, normal levels of
challenge with the parasite extract. Mice that received IL-12 accumulated in supernatants of spleen cells from
PBS followed 48 hr later by STAg had high (.20 ng/ml) STAg→PBS and STAg→STAg mice after restimulation
levels of serum IL-12 p40 24 hr after the second injection with STAg in vitro (Figure 2A, shaded bars), despite the
(Figure 3A). This compares to a level of 3.0 6 0.6 ng/ml fact that the cells did not make the cytokine spontane-
in unstimulated mice (data not shown). In contrast, mice ously in medium alone (Figure 2A, dotted bars). DC from
that received STAg 48 hr prior to a secondary challenge STAg→PBS and STAg→STAg mice also stained for
with STAg had less than half the amount of serum cyto- IL-12 p40 after culture with STAg but not after incubation
kine 24 hr after STAg rechallenge (Figure 3A). These in medium alone (data not shown). These results suggest
results indicate that paralysis of the IL-12 response oc- that STAg induces DC paralysis in vivo but that paralysis
curs systemically, although to a lesser extent than in is reversible in vitro. In contrast, spleen cells from mice
the spleen. given PBS followed by LPS (PBS→LPS) or vice versa
(LPS→PBS) failed to produce IL-12 after STAg stimula-
tion in vitro (Figure 2A). This is consistent with the notionDC Paralysis Is Reversible In Vitro
The selective abrogation of the IL-12 response of DC to that LPS induces death rather than paralysis of DC (see
above).secondary STAg stimulation could be due to intrinsic
Paralysis of Dendritic Cell IL-12 Production
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Figure 3. STAg-Induced Paralysis Results in
Suppression of the Systemic IL-12 Response,
Occurs Independently of Lymphocytes and
IL-10, and Is Transient
(A) C57BL/6 mice (4±5/group) were injected
on day 22 with either PBS or 25 mg STAg fol-
lowed by a second STAg injection on day 0.
Serum IL-12 p 40 levels were measured 24 hr
later. (B and C) Groups of C57BL/6-scid (B)
or C57BL-IL-10 KO (C) and their wild-type
counterparts were injected on day 21 with
either PBS or 25 mg STAg and subsequently
injected with STAg (25 mg) 24 hr later. Six
hours after the second STAg injection, sple-
nocytes were harvested and spontaneous IL-
12 p40 production measured in supernatants
obtained after overnight culture. Experiments
are representative of two performed. (D)
C57BL/6 mice (3±4/group) were injected i.v.
with STAg (25 mg), and at the time points
indicated the animals were reinjected with ei-
ther STAg (25 mg) or PBS and then sacrificed
6 hr later. Spleen cell suspensions from the
mice were then incubated for 24 hr and IL-
12 p40 was measured in the supernatants by
ELISA. A similar recovery of IL-12 respon-
siveness to STAg was seen in a repeat experi-
ment using different assay times. The data
in (A)±(D) are means 6 SD of values for the
individual mice in each group.
It remained possible that the cells from paralyzed mice Paralysis of the IL-12 Response Is Not Due to IL-10
or Lymphocyte Suppressionthat made IL-12 in response to STAg stimulation in vitro
were cells other than DC. To address this issue, we The above results suggested that DC paralysis might
be due to an immunosuppressive environment in vivopurified CD8a2 and CD8a1 DC, as well as DC-depleted
spleen cells (CD11c2), and stimulated them indepen- that was disrupted after spleen cell isolation. To address
the mechanism of paralysis, we assessed whether itdently in vitro. Spleen cell suspensions from mice in-
jected with PBS or STAg 24 hr previously were stained could be induced in SCID mice lacking both T and B
lymphocytes. As shown in Figure 3B, there was greaterwith antibodies against CD11c and CD8 in the presence
of anti-Fcg receptor antibody. Spleen subpopulations accumulation of IL-12 in the culture supernatants of
splenocytes from STAg-injected SCID mice than fromwere then sorted to 90% or greater purity (data not
shown) and cultured for 24 hr in medium alone or supple- wild-type controls, probably due to enrichment of the
IL-12-producing cells resulting from the absence of lym-mented with STAg. Spleen cells from PBS-injected (ªna-
iveº) or STAg-injected (paralyzed) mice did not make IL- phocytes (Reis e Sousa et al., 1997). However, IL-12
production in response to STAg was abrogated when12 spontaneously but did so if cultured with STAg (Figure
2B, total spleen). The binding of the antibodies used for either wild-type or SCID mice were preexposed to the
antigen. Similar results were obtained in RAG-deficientsorting did not alter the amount of IL-12 produced by
spleen cell cultures (Figure 2B; compare total spleen mice (data not shown). Thus, paralysis of IL-12 produc-
tion in vivo can occur in the absence of T or B lympho-unlabeled and total spleen labeled). However, depletion
of CD11c1 cells greatly decreased the amount of IL-12 cyte products or DC-lymphocyte interactions. IL-10
cross-regulation was also not the cause of the paralysismade in response to STAg, suggesting that DC acted
as the main source of the cytokine in spleen cell cultures because suppression of the IL-12 response to STAg
could be induced in IL-10-deficient mice by preinjection(Figure 2B). Moreover, high amounts of IL-12 accumu-
lated in supernatants of purified DC from either naive of the extract (Figure 3C). Thus, DC paralysis is due
to an immunomodulatory effect independent of eitheror paralyzed mice cultured with STAg (Figure 2B). Only
CD8a1 DC produced IL-12 among spleen cells from lymphocytes or IL-10.
naive mice, as expected. However, in spleen cell sus-
pensions from paralyzed mice both the CD8a2 and Restoration of DC Responsiveness to STAg Occurs
Concurrently with Reacquisition of NormalCD8a1 DC subsets produced roughly equivalent levels
of IL-12 (Figure 2B). These results demonstrate that DC DC Distribution
The kinetics of restoration of the response to STAg wereparalysis is exclusively an in vivo phenomenon that can
be reversed in vitro. This reversibility confirms that paral- studied in previously paralyzed animals. Mice injected
with STAg on day 0 were rechallenged with the sameysis cannot be attributed to DC death, loss of DC respon-
siveness, or replacement of the original splenic CD8a1 stimulus or with PBS at different days after initial expo-
sure. Spleen cell suspensions were then cultured for 24DC population with cells incapable of making IL-12.
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hr to measure spontaneous IL-12 release. As before,
mice given a single injection of STAg produced IL-12
on day 0 (6 hr after challenge), but this response was
lost by day 1 and subsequent days (Figure 3D [mice
reinjected with PBS]). Mice reinjected with STAg 24 hr
after the first challenge showed paralysis of IL-12 pro-
duction. By 4 days after the initial challenge, a slight
restoration of the response was observed in that IL-12
levels in cultures of STAg rechallenged mice were higher
than in those from PBS rechallenged animals (Figure
3D). This trend continued thereafter such that the full
response to STAg was obtained again by 5±7 days after
primary injection (Figure 3D).
Immunohistochemical analysis of serial spleen sec-
tions was used to analyze the distribution of CD11c1
cells during the recovery from paralysis. CD11c1 cells
showed a marked redistribution within the spleen 6 hr
after STAg challenge (Figure 1B, left side), accumulating
in the T cell areas as reported (Reis e Sousa et al., 1997).
Twenty-four hours after STAg challenge, CD11c1 cells
were found both within and outside T cell areas, but this
distribution was markedly different from that seen in the
resting state (Figure 1B, left side; data not shown). STAg
rechallenge at this time point did not alter the localiza-
tion of the cells in any obvious way and did not result
in immunodetectable IL-12 (Figure 1B, right side). The
localization of CD11c1 cells gradually changed over the
next few days after primary stimulation such that by day
7 the normal DC distribution in the spleen was restored
(Figure 1B, left side; compare no STAg control with day
7 STAg). Reinjection of STAg at this time once again
caused redistribution of the CD11c1 cells, which colo-
calized with the IL-12 staining (Figure 1B, right side).
Thus, the restoration of STAg-induced IL-12 respon-
siveness in mice coincides with restoration of normal
DC distribution in the spleen.
Paralysis of DC IL-12 Production Protects against
Parasite-Induced Immunopathology
The observation (Figure 3A) that STAg preinjection re-
sults in reduced serum levels of IL-12 upon rechallenge
suggested that paralysis of DC function could lead to Figure 4. STAg Pretreatment Decreases Systemic Cytokine and Se-
suppression of IL-12-dependent cellular immune func- rum Transaminase Levels in T. gondii-Infected Wild-Type, IL-10-
Deficient, and RAG-2-Deficient Micetion induced systemically by live T. gondii infection. To
test this hypothesis, we challenged STAg preexposed Groups of five WT, IL-10-deficient, or RAG-deficient mice were pre-
injected with either PBS or 25 mg of STAg on day 21 and subse-mice with the avirulent ME-49 strain of T. gondii. Al-
quently infected intraperitoneally on day 0 with 20 T. gondii cysts.though both IL-12 and IFNg responses to the parasite
Serum levels of IL-12 p40 (A) and IFNg (B) were determined on daywere found to be markedly reduced as a consequence
5 while serum AST activity (C) was measured at 8 days post infection.
of presensitization (Figures 4A and 4B), this suppression The results shown are the mean 6 SD of the values determined for
was not sufficient to result in decreased host survival the five mice per group.
or increased parasite burden as assessed by tissue cyst
levels (data not shown). Interestingly, a similar suppres-
sion of serum IL-12 response was observed in STAg- IL-12-dependent production of IFNg can also lead to
host immunopathology, a situation that in IL-10 KO micepreinjected, ME-49-challenged RAG2/2 mice (Figure
4A), confirming that the observed paralysis is T cell inde- results in rapid death within 2 weeks after infection with
ME-49 (Gazzinelli et al., 1996; Neyer et al., 1997). Be-pendent. Although serum IFNg levels in the RAG2/2 ani-
mals were clearly lower than those in wild-type animals cause DC paralysis can be induced in IL-10 KO mice
(Figure 3C), we reasoned that it might prevent their mor-challenged in parallel (reflecting the known involvement
of CD41 cells in the early IFNg response [Gazzinelli et al., tality. As shown in Figure 5A, preinjection with STAg 24
hr before parasite challenge completely protected IL-101994]), STAg presensitization also resulted in a profound
reduction in serum IFNg production in these T cell± KO animals from acute death. This protection correlated
with a marked decrease in serum IL-12 and IFNg levelsdeficient hosts (Figure 4B).
In addition to mediating host resistance to T. gondii, during the first 6 days post infection (Figures 4A, 4B,
Paralysis of Dendritic Cell IL-12 Production
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Kinetic Correlation between Paralysis of DC IL-12
Response and Systemic Cytokine Production
Although STAg preinjection resulted in extended protec-
tion of IL-10 KO mice against infection-induced mortal-
ity, the reduction in systemic cytokine production in-
duced in these animals was clearly transient. Thus, as
shown in Figures 5B and 5C, by 6 days post infection,
serum IL-12 and IFNg levels were clearly rebounding in
STAg-treated ME-49-challenged animals. It is striking
that the observed recovery in serum cytokine responses
in STAg preinjected mice correlates kinetically with the
restoration in spleen cell IL-12 production documented
both in vitro (Figure 3D) and in situ (Figure 1B). Thus,
both responses appear to return to control levels by
7 days post STAg treatment. This correlation strongly
implicates DC paralysis as the likely explanation for the
suppression in systemic cytokine production and immu-
nopathology seen after parasite challenge.
Discussion
The phenotype and function of dendritic cells can be
modulated by a variety of microbial stimuli, including
lipopolysaccharide (LPS), viral RNA, intact bacteria, and
parasite extracts (Reis e Sousa et al., 1999). Nonethe-
less, the role of dendritic cells in the initiation of immune
responses to infection is poorly understood. We ob-
served that CD8a1 DC can serve as a rapid in vivo
source of IL-12, a cytokine crucial in protection from
infection by intracellular parasites (Reis e Sousa et al.,
1997). Here, we extend our previous studies to show
that following the response to parasite products, DC
enter a state in which IL-12 production is downregulated
and refractory to further stimulation in vivo. Nonethe-
less, IL-12 is produced if the cells are restimulated in
vitro. Associated with this refractory state of DC, there
is a reduction in the level of circulating IL-12 upon rechal-
lenge, suggesting that paralysis occurs at the systemic
level. Paradoxically, in some cases, paralysis of IL-12
production by DC can be beneficial to the host because
it minimizes the immunopathology resulting from unreg-
ulated production of the cytokine. A dramatic example
occurs in IL-10-deficient mice in which pretreatment
with the parasite extract protects against mortality in-Figure 5. Paralysis Promotes Survival of T. gondii-Infected IL-10-
duced by infection with a nonvirulent strain of T. gondii.Deficient Mice
CD8a1 DC have been postulated to belong to a specialEffect of STAg pretreatment on the survival (A) and systemic cyto-
kine responses (B and C) of T. gondii-infected IL-10-deficient mice. lineage of DC of lymphoid origin specialized to induce
Groups of five IL-10-deficient mice were preinjected i.v. with either T cell tolerance (Kronin et al., 1996; Suss and Shortman,
25 mg of STAg or PBS on day 21 and subsequently infected with 1996; Inaba et al., 1997; Shortman et al., 1997; Fazekas
20 T. gondii (ME49) cysts intraperitoneally on day 0. In (A), survival
de St Groth, 1998). Nonetheless, recent reports haveof infected mice was monitored daily for 30 days. Separate groups
suggested that these cells also promote potent T cellof PBS or STAg-pretreated animals were bled on days 0, 2, 4, and
immunity (Maldonado-LoÂ pez et al., 1999; Pulendran et6 and the levels of IL-12 p40 (B) and IFNg (C) in sera determined
by ELISA. The values shown are the means of the cytokine levels al., 1999; Smith and Fazekas de St Groth, 1999). Addi-
at each time point for the five mice per group. tional observations support an inductive rather than in-
hibitory role for CD8a1 DC. For example, STAg or LPS
stimulation results in upregulation of CD40, B7-1, and5B, and 5C), as well as reductions in serum aspartate
transaminase (AST) (Figure 4C), a liver enzyme that B7-2 costimulatory molecules on CD8a1 DC concomi-
tant with inducing IL-12 (our unpublished data). In addi-serves as a readout of hepatic pathology. The enhanced
survival of the STAg-treated IL-10 KO mice was not due tion, coimmunization with a protein antigen and LPS
greatly enhances the frequency of antigen-loaded MHCto the elimination of the challenge since these animals
contained large numbers of brain cysts (525 6 150 in class II molecules on CD8a1 DC (Reis e Sousa and
Germain, 1999; S. Manickasingham and C. R. S., unpub-IL-10 KO versus 650 6 229 in WT mice) when necropsied
at 30 days post infection. lished data). These observations raise the question of
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whether there are subsets of CD8a1 DC specialized to of recovery from paralysis paralleled the reacquisition
of normal DC distribution in the spleen. A turnoverinduce immunity versus tolerance or whether CD8a1 DC
can perform either tolerogenic or inductive roles in the period of 7 days has been observed previously for mar-
ginal zone splenic DC (Leenen et al., 1998), similar toimmune response depending on prior exposure to cer-
tain stimuli. Interestingly, although only CD8a1 DC pro- the time taken by CD11c1 cells to reappear in marginal
zone bridging channels of spleens from STAg-injectedduce IL-12 after primary STAg challenge, CD8a2 DC can
clearly also make the cytokine in some circumstances, mice (Figure 1). It is of course possible that paralysis is
due to changes in the levels of the putative immunosup-such as after in vivo priming (Figure 2B). Whether this
reflects additional requirements of CD8a2 DC for IL-12 pressive factor rather than its receptor. In that case,
even naive DC would be paralyzed, and the restorationproduction or whether the relationship between CD8a2
and CD8a1 DC is much closer than appreciated remains of the response to STAg might require the gradual loss
of the downmodulatory mediator over a 7 day period.to be determined. Nonetheless, these results suggest
that the notion of CD8a1 DC as the sole initiators of Th1 The marked IL-12 unresponsiveness seen following
initial STAg treatment suggested that DC paralysisresponses is likely to be overstated (Maldonado-LoÂ pez
et al., 1999; Pulendran et al., 1999). should have immunoregulatory consequences affecting
the host response to T. gondii infection. Indeed, priorImmature DC stimulated with certain microbial prod-
ucts such as LPS undergo an irreversible differentiation STAg injection resulted in marked suppression of sys-
temic IL-12 as well as IFNg responses in both WT andprocess that culminates in apoptotic death (De Smedt
et al., 1996, 1998; Winzler et al., 1997). Our results sug- IL-10-deficient mice during acute infection. In the case
of IL-10-deficient animals, this inhibition was sufficientgest that even when the cells survive, their ability to
respond to further microbial stimulation is profoundly to protect them against the IL-12/IFNg-dependent le-
thality induced by T. gondii infection and was reflectedaltered. The observation that DC paralyzed in vivo are
nevertheless fully responsive to STAg in vitro (Figure 2) in decreased serum transaminase levels, a marker of
hepatic pathology. Previous reports indicated that tran-could be explained by the existence of a factor that
suppresses DC IL-12 production locally in the PALS sient depletion of CD41 T cells or IFNg can temporarily
rescue these IL-10-deficient hosts from acute mortalitywhile being present at levels insufficient to block the
same response in culture. However, IL-12 paralysis is not (Gazzinelli et al., 1996; Neyer et al., 1997). In the present
instance, STAg pretreatment also resulted in a transientattributable to IL-10, the cytokine that usually counter-
regulates IL-12 production (Trinchieri, 1998), or to inter- (7 day) reduction of IL-12 and IFNg that was sufficient
to protect the infected IL-10 KO mice not only duringactions between DC and lymphocytes. Other candidate
mediators include TGF-b, IL-11, TNF, prostaglandins, the early acute phase, but also to allow their survival
into the chronic stage of infection. These observationsand/or steroids, all of which can inhibit IL-12 production
by monocytes/macrophages (Kalinski et al., 1997; Leng suggest that the Th1-dependent immunopathology re-
sulting from the absence of IL-10 occurs during a criticaland Elias, 1997; Rieser et al., 1998; Vieira et al., 1998).
Interestingly, the suppression of IL-12 production ob- window within the first week of infection. Once the in-
fected host survives this vulnerable period, immunoreg-served during the induction of endotoxin tolerance in
both human monocytes and DC is also IL-10 (and TGF-b) ulatory mechanisms/mediators other than IL-10 may
come into play that prevent lethality despite the ongoingindependent (Karp et al., 1998) and can be mimicked
by prostaglandin E2 treatment (Rieser et al., 1998). How- Th1 cytokine response required to prevent reactivation
of infection and lesion development. Thus, the host pro-ever, there are substantial differences between STAg-
induced DC paralysis and LPS tolerance. Spleen cells tective role of IL-10 appears to be limited largely to the
acute stage of infection when tachyzoite proliferation istaken from LPS-injected mice no longer respond to
STAg in vitro (Figure 2), consistent with the notion that at its greatest and CD41 T cells are mounting their initial
vigorous IFNg response against the replicating pro-LPS induces DC death rather than what we have called
paralysis. Furthermore, unlike LPS tolerance (Karp et al., tozoa.
Our observation that both WT and IL-10 KO mice in1998), STAg-induced DC paralysis cannot be induced in
vitro (data not shown). The latter observation greatly which DC have been made IL-12 deficient by STAg pre-
treatment display normal control of infection raises thecomplicates the dissection of the molecular mecha-
nisms underlying paralysis but is consistent with the issue of whether the production of this cytokine by DC
plays an essential role in either innate or adaptive hostidea that this form of regulation depends on anatomi-
cally restricted factors operative in the T cell areas of resistance to T. gondii. However, it is important to note
that paralysis fails to result in the complete and perma-lymphoid tissues.
How could an immunosuppressive factor constitu- nent blockade of the systemic IL-12/IFNg response (Fig-
ures 3A and 4B), a situation distinct from that occurringtively present in the PALS mediate paralysis of pre-
viously activated DC while allowing the activation of in IL-12 or IFNg KO mice, both of which are highly sus-
ceptible to infection. Instead, we favor the view that DCnaive cells? A simple model would be that microbial
challenge leads to the upregulation of a DC receptor paralysis tempers the IL-12 response to a level sufficient
for localized release of IFNg and activation of effectorfor the putative factor, ensuring that susceptibility to
suppression is strictly coupled to APC activation. If this cells while preventing the accumulation of excessive
IFNg in the circulation and the ensuing collateral damageis correct, the restoration of the response to STAg might
require the turnover of the previously activated DC pool to bystander tissues.
A further and perhaps more important question raisedand reconstitution of the spleen and peripheral sites
with naive DC derived from bone marrow precursors. by these findings is whether the observed downregula-
tion in systemic IL-12 responsiveness seen followingThis is consistent with our observation that the kinetics
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The animals employed were 6±10 weeks old and both age and sexSTAg injection is a direct consequence of the observed
matched. None of the IL-10-deficient mice developed the spontane-paralysis in DC function. Direct proof has been difficult
ous colitis associated with older mice of this strain (Berg et al., 1996)to obtain because of our inability to obtain sufficient
during the course of our experiments.
numbers of CD8a1 DC for performing the appropriate
reconstitution experiment. Nevertheless, three pieces
Preparation and Injection of Tachyzoite Antigen
of evidence support a causal relationship. First, both Soluble tachyzoite antigen was prepared from tachyzoites of the
DC paralysis and systemic suppression of IL-12/IFNg RH 88 strain of T. gondii cultured in human foreskin fibroblasts as
responsiveness occur in the absence of functional T or described (Grunvald et al., 1996). All cultures were routinely
screened by PCR for possible Mycoplasma contamination using aB cells, arguing that both phenomena result directly
kit obtained from the American Type Culture Collection (Manassas,from intrinsic impairment of DC. Second, neither form
VA). Unless otherwise stated, STAg was administered to mice i.v.of nonresponsiveness is due to IL-10. Finally and most
at a dose of 25 mg per mouse diluted in 0.2±0.3 ml of PBS or 5±25
importantly, DC paralysis and systemic IL-12/IFNg sup-
mg i.p. in 200 ml PBS. Either dose and route produces identical
pression are both transient and show comparable recov- results (data not shown), and in later experiments doses as low as
ery times (Figures 3D and 5). While these shared proper- 2.5 mg were shown to have equivalent effects. PBS was used as a
vehicle alone control.ties do not formally rule out the possibility of divergent
underlying mechanisms, they make such an explanation
Spleen Cell Cultures and Cytokine Assaysseem improbable.
Single cell suspensions were prepared from spleens harvested atDC are likely to participate in type 1 host defense
4±6 hr after the indicated mouse treatments. Cells were plated atagainst intracellular parasites at two different levels.
2±6 3 105 per well in 96-well plates in RPMI 1640 medium supple-First, they could promote an IL-12-dependent protective
mented with 10% FCS, penicillin (100 units/ml), streptomycin (100
Th1 response to parasite antigens during the adaptive mg/ml), glutamine (2 mM), and b-mercaptoethanol (5 3 1025 M)
phase of the immune response. Such a function is con- (complete medium). Cultures were then incubated in the presence
or absence of STAg (5 mg/ml), and supernatants were collectedsistent with the well-accepted role of DC in T cell priming
at 18±24 hr for IL-12 p40 determination using a sandwich ELISAand recent observations that antigen-pulsed dendritic
(Scharton-Kersten et al., 1996).cells induce high levels of protective immunity against
intracellular parasites (Reis e Sousa et al., 1999). A sec-
Flow Cytometryond, less appreciated, function of DC may be in promot-
Spleen cell suspensions prepared by collagenase digestion (Swig-ing T cell±independent early protection against infec-
gard et al., 1991) were washed with PBS/5 mM EDTA and stained
tion, perhaps through NK cells (Fernandez et al., 1999). with the indicated mAbs in PBS/EDTA containing 1% FCS, as de-
By presenting evidence for a necessary link between scribed (Reis e Sousa et al., 1997; Reis e Sousa and Germain, 1999).
DC function and the early, nonadaptive phase of the For intracellular cytokine staining, cells were fixed in 1% paraformal-
dehyde in PBS/EDTA for 10 min, washed, and kept overnight incytokine response to natural infection with T. gondii, the
PBS/EDTA containing 1% FCS. The next day, cells were washeddata presented here support a role for DC in innate
and stained in buffer containing 0.1% saponin. 300,000±500,000immunity. More direct proof of the concept has been
events were collected on a FACS Calibur cytometer (Becton-Dickin-
difficult to obtain because of the unavailability of DC- son) and were analyzed using FlowJo software (TreeStar). The fol-
deficient mice and because of technical limitations in lowing antibodies were used: C17.15.10 (Wysocka et al., 1995), a
detecting activated DC in tissues invaded by T. gondii rat IgG2a against mouse IL-12 p40; N418 (Metlay et al., 1990) and
HL3 (Huleatt and Lefrancois, 1995) (PharMingen), hamster IgG mAbsdue to the low frequency of cell-parasite encounters
against CD11c; and 53-6.7 (Ledbetter and Herzenberg, 1979), a ratduring natural exposure. Regardless, the results of the
IgG2a anti-CD8a (PharMingen). Irrelevant isotype-matched antibod-present study argue that the induction of DC function
ies (PharMingen) were used as controls to validate the specificity
during initial microbial encounter is likely to be a tightly of staining.
regulated process that may promote, as well as pro- For apoptosis detection, anti-CD11c-FITC and anti-CD8a-
vide a natural ªbrakeº on, IFNg-dependent immunity, CyChrome stained cells were incubated for 20 min in the presence
of Annexin V-PE (R&D Systems) at room temperature, followed byallowing its initiation while avoiding the host detrimental
addition of binding buffer and propidium iodide (PI) (50 mg/ml) andconsequences of an excessive IL-12-driven cytokine re-
immediate acquisition in a cytometer, as recommended by the man-sponse.
ufacturer. Numbers of apoptotic cells were determined by analyzing
the frequency of Annexin V1 PI2 subsets within CD11c1 CD8a2 or
CD11c1 CD8a1 spleen cell populations.Experimental Procedures
For sorting of spleen cell subsets, red blood cells were lysed in
buffered ammonium chloride, and splenocytes were stained withExperimental Animals
PE-HL3 and FITC-53-6.7 in the presence of 2.4G2 (Unkeless, 1979)C57BL/6 or CBA mice used routinely in most experiments were
supernatant. CD11c2, CD11c1 CD8a2, and CD11c1 CD8a1 subsetsobtained from the Division of Cancer Treatment, National Cancer
were sorted in a FACS Vantage (Becton-Dickinson) or MoFlo (Cyto-Institute (Frederick, MD) or from the breeding unit of the Imperial
mation) cytometer. The gates used for sorting were checked withCancer Research Fund (Clare Hall, South Mimms, UK). C57BL/6-
appropriate specificity controls. The purity of sorted cells wasscid/SzJ mice were purchased from The Jackson Laboratory (Bar
checked by FACS analysis using TOPRO staining of dead cellsHarbor, ME) and bred at the NIAID animal facility (Bethesda, MD).
(Molecular Probes).IL-10-deficient mice were obtained from the NIAID mouse breeding
contract at Taconic Farms (Taconic, NY). These mice were bred
from a stock originally provided by W. Muller (University of Cologne) Immunohistochemistry
Frozen spleen sections were processed and stained with the indi-(Kuhn et al., 1993) and had been backcrossed for 10 generations
onto a C57BL/10Sc/Sn background. RAG-22/2 mice backcrossed cated antibodies as previously described (Reis e Sousa et al., 1997).
The apoTACS TUNEL staining kit (R&D Systems) was used to detectfor two generations on the same C57BL/10 background as well as
wild-type C57BL/10 animals were also obtained from Taconic apoptotic cells, as detailed by the manufacturer. Stained sections
were photographed on a Leica compound microscope (Leica) con-Farms. All mice obtained from the Taconic source had been rede-
rived by Caesarean into a specific pathogen-free barrier facility. nected to a digital video camera.
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Experimental Infection of STAg Pretreated Animals characterization and protein kinase C dependency of monokine-
inducing activities of Toxoplasma gondii. Infect. Immun. 64, 2010±Wild-type or IL-10-deficient mice were injected i.v. with 25 mg of
2018.STAg 1 day prior to infection with 20 cysts of the avirulent ME-49
strain suspended in PBS (i.p. injection). Survival of infected mice Howard, M., Muchamuel, T., Andrade, S., and Menon, S. (1993).
was monitored daily until 30 days post infection. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med.
177, 1205±1208.
Hsieh, C.-S., Macatonia, S.E., Tripp, C.S., Wolf, S.F., O'Garra, A.,Measurement of Cytokines and Liver Enzymes in Serum
and Murphy, K.M. (1993). Development of TH1 CD41 T cells throughAt the intervals indicated, mice were bled and sera collected for
IL-12 produced by Listeria-induced macrophages. Science 260,determination of circulating levels of IL-12 p40 and IFNg by ELISA,
547±549.as described previously (Scharton-Kersten et al., 1996). Serum AST
levels were also measured as a marker of liver pathology. For this Huleatt, J.W., and Lefrancois, L. (1995). Antigen-driven induction of
assay, mice were bled by cardiac puncture 8 days post infection, CD11c on intestinal intraepithelial lymphocytes and CD81 T cells
and sera were submitted to the Clinical Pathology Department of in vivo. J. Immunol. 154, 5684±5693.
the Clinical Center, NIH, for determination of AST using a commercial Inaba, K., Pack, M., Inaba, M., Sakuta, H., Isdell, F., and Steinman,
kit (Boehringer Mannheim) in a Hitachi #917 Automatic Analyzer. R.M. (1997). High levels of a major histocompatibility complex II-
AST levels are reported as IU/l of serum. Mean AST levels in unin- self peptide complex on dendritic cells from the T cell areas of
fected mice were 204 6 60 IU/l. lymph nodes. J. Exp. Med. 186, 665±672.
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